GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -95.74% | -96.10% | 8.15% | 21.67% | 567.15% |
| Total Receivables | 13.04% | 3.33% | -22.36% | -12.66% | -74.61% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -60.69% | -64.06% | -83.86% | -81.84% | -84.10% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -78.76% | -80.58% | 53.51% | 72.70% | 82.55% |
| Total Current Assets | -77.15% | -79.11% | -23.35% | -13.77% | -12.21% |
|
|
|||||
| Total Current Assets | -77.15% | -79.11% | -23.35% | -13.77% | -12.21% |
| Net Property, Plant & Equipment | -45.00% | -49.73% | -56.85% | -51.45% | -12.07% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -36.92% | -42.28% | -28.83% | -19.90% | -22.90% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 724.47% | 653.63% | 723.58% | 826.58% | -7.38% |
| Total Assets | -46.24% | -50.86% | 10.32% | 24.12% | -12.10% |
|
|
|||||
| Total Accounts Payable | 96.21% | 79.34% | 5.68% | 18.90% | -58.50% |
| Total Accrued Expenses | 76.18% | 61.03% | -9.21% | 2.13% | -54.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 129.53% | 109.79% | -25.10% | -15.73% | -57.51% |
| Total Finance Division Other Current Liabilities | -85.11% | -86.39% | 20.73% | 35.82% | 826.57% |
| Total Other Current Liabilities | -85.11% | -86.39% | 20.73% | 35.82% | 826.57% |
| Total Current Liabilities | 66.55% | 52.23% | -16.23% | -5.76% | -45.89% |
|
|
|||||
| Total Current Liabilities | 66.55% | 52.23% | -16.23% | -5.76% | -45.89% |
| Long-Term Debt | -66.68% | -69.55% | -13.80% | -3.02% | 183.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.11% | -36.12% | -54.07% | -48.31% | -14.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 38.61% | 26.69% | 9.91% | 23.65% | -5.62% |
| Total Liabilities | 8.61% | -0.73% | -11.41% | -0.33% | -10.78% |
|
|
|||||
| Common Stock & APIC | 13.39% | 3.65% | 2.01% | 14.76% | 9.75% |
| Retained Earnings | -30.58% | -19.35% | 49.99% | 43.73% | 52.02% |
| Treasury Stock & Other | -16.10% | -6.12% | -5.83% | -19.06% | -10.79% |
| Total Common Equity | -41.70% | -29.52% | 17.87% | 7.60% | 9.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -41.70% | -29.52% | 17.87% | 7.60% | 9.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -41.70% | -29.52% | 17.87% | 7.60% | 9.96% |
|
|
|||||